Cargando…
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer
SIMPLE SUMMARY: Pre-clinical models are required to develop new therapeutics to improve patient care. In the prostate cancer field, significant progress has been made in the development of in vivo models but with a predominant focus on transgenics, which are time and cost prohibitive. Conversely, ot...
Autores principales: | Haughey, Charles M., Mukherjee, Debayan, Steele, Rebecca E., Popple, Amy, Dura-Perez, Lara, Pickard, Adam, Patel, Mehjabin, Jain, Suneil, Mullan, Paul B., Williams, Rich, Oliveira, Pedro, Buckley, Niamh E., Honeychurch, Jamie, S. McDade, Simon, Illidge, Timothy, Mills, Ian G., Eddie, Sharon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599844/ https://www.ncbi.nlm.nih.gov/pubmed/33003551 http://dx.doi.org/10.3390/cancers12102804 |
Ejemplares similares
-
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
por: Colton, Madyson, et al.
Publicado: (2020) -
Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?
por: Romano, Erminia, et al.
Publicado: (2021) -
The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy
por: Frankish, Jamie, et al.
Publicado: (2023) -
Radiotherapy transiently reduces the sensitivity of cancer cells to lymphocyte cytotoxicity
por: Tuomela, Karoliina, et al.
Publicado: (2022) -
Synchronous apoptosis in established tumors leads to the induction of adaptive immunity
por: Honeychurch, Jamie, et al.
Publicado: (2013)